×

Reimbursement

shutterstock_107572736

Labor’s Cancer Care Policy and the Australian Constitution

By Sarah Griffin | 1 May, 2019
The Australian Constitution and Labor’s Cancer Care Policy. As we ever so slowly move towards the Australian Federal Election, both major parties are presenting their health policies. Labor has promised...
Distribution copy

The commercialization continuum: beyond product registrations

By Luis Jimenez | 4 March, 2019
Your product is approved, now what? This is a question that can bring a painful realization to medical technology manufacturers and suppliers eagerly entering a new market. The appropriate preparation...
shutterstock_88704472

Cardiac Ablation Catheters included on the March 2019 Prostheses List

By Sarah Griffin | 1 March, 2019
The Prostheses List is a list of implantable medical devices for which Australian private health insurers must pay a specific benefit over and above any payment for the associated hospital...

Search

Recent Posts

Some Class I Device Transitions Extended – MDR

Feb 3, 2020

And out they go…BREXIT is final! But what about Australia?

Jan 30, 2020

TGA acceptance of international device reviews – clearing the fog

Dec 20, 2019

Brexit appears inevitable – and it seems UK MHRA will emulate New Zealand!

Dec 19, 2019

A single review program for medical devices?

Dec 2, 2019

The door to Europe is closed – so where else should I look?

Dec 2, 2019

Categories

Categories

Archives

Archives

Archives

Tags

3D 510(k) AIMD APAC Australia Biocompatibility Brexit CE CE Certificates clinical trials de novo distribution EU Europe FDA GHTF guidance Harmonization IMDRF IVD IVDD IVDR MDD MDR MDSAP medical device Medical Device Regulations medical devices medicines MHRA New Zealand Notified Bodies PMA PMDA postmarket private health insurance QMS Quality Systems Reform Reimbursement SaMD Software standards TGA UDI
Translate »